A Study of SHR-1316 and Fluzoparib（SHR-3162） in Small Cell Lung Cancer Patients
Status:
Unknown status
Trial end date:
2020-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of SHR-1316 in combination
with Fluzoparib（SHR-3162） in Small Cell Lung Cancer Patients